Date published: 2025-12-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

MYLK Activators

MYLK, or Myosin Light Chain Kinase, is an enzyme that plays a pivotal role in the regulation of muscle contraction in many cell types, primarily through its ability to phosphorylate the myosin regulatory light chain (MRLC). This phosphorylation facilitates the interaction between actin and myosin, which is integral to muscle contraction and cellular motility processes. MYLK is found in various cells, including smooth muscle cells, and its activity is regulated by a complex interplay of signaling molecules and pathways. Given the crucial functions of MYLK in cellular physiology, understanding its activators and modulators becomes highly significant. MYLK activators, as the name suggests, are chemical entities or biological factors that can enhance the activity of MYLK. These activators may operate through a direct interaction with the enzyme or indirectly by modulating upstream signaling pathways that converge on MYLK. For instance, an increase in intracellular calcium levels can activate calmodulin, a protein that binds to and activates MYLK. On the other hand, certain signaling molecules, like RhoA or its downstream effector Rho-kinase (ROCK), can indirectly influence MYLK activity by inhibiting its opposing phosphatases. These interactions underscore the sophisticated and interconnected nature of cellular signaling cascades where MYLK finds itself at an important juncture. As research delves deeper into the intricacies of MYLK function and regulation, a comprehensive understanding of its activators will provide a clearer picture of various physiological and pathological cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Angiotensin II, Human

4474-91-3sc-363643
sc-363643A
sc-363643B
sc-363643C
1 mg
5 mg
25 mg
100 mg
$50.00
$75.00
$260.00
$505.00
3
(1)

Angiotensin II, Human is a potent peptide hormone that plays a critical role in regulating blood pressure and fluid balance. It interacts specifically with angiotensin receptors, triggering a cascade of intracellular signaling pathways that influence vascular smooth muscle contraction and aldosterone secretion. Its rapid kinetics allow for swift physiological responses, while its unique structure facilitates high-affinity binding, enhancing its effectiveness in modulating cardiovascular functions.

Calcium

7440-70-2sc-252536
5 g
$209.00
(0)

As mentioned, the primary activator of MYLK is the calcium ion, especially when it binds to calmodulin, forming the calcium-calmodulin complex.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

While this is traditionally known as an inhibitor of MYLK, in certain concentrations and contexts, it might produce varying effects on MYLK activity.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

This is a broad-spectrum kinase inhibitor, but again, in specific settings, it might modulate MYLK activity.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$163.00
$300.00
$1642.00
18
(1)

This is a calmodulin antagonist, which can affect MYLK's activation state by inhibiting its primary activator, calmodulin.

(±)-Blebbistatin

674289-55-5sc-203532B
sc-203532
sc-203532A
sc-203532C
sc-203532D
5 mg
10 mg
25 mg
50 mg
100 mg
$179.00
$307.00
$455.00
$924.00
$1689.00
7
(1)

While mainly an inhibitor of myosin II, it's noteworthy for researchers studying MYLK because of its influence on the broader myosin pathway.